Robitaille P, O'Regan S, Mongeau J G, Freeman C, Lortie L, Yazbeck S
Int J Pediatr Nephrol. 1985 Apr-Jun;6(2):133-6.
Between 1974-1979, 64 renal cadaveric transplants were performed in 54 pediatric recipients at our institution. Forty eight of these 64 transplants experienced at least one episode of acute rejection. These patients were divided in two equal groups including 24 transplants in 21 recipients, one group treated with chemical immunosuppression alone, the other group treated by chemical immunosuppression and radiotherapy. Kidney survival at 2 years was 54.1% (13/24) in the control group treated by chemical immunosuppression alone. In the group treated by radiotherapy and immunosuppression, kidney survival after 2 years gave a success rate of 45.8% (11/24). Thus, it would appear that addition of radiotherapy to standard immunosuppressive treatment exerted no beneficial long term effect in acutely rejected renal transplants. In view of the disappointing results obtained with radiotherapy, it is felt that this mode of treatment should be restricted to use in particular circumstances as a temporary means of immunosuppression where systemic immunosuppression is hazardous.
1974年至1979年间,我们机构对54名儿科受者进行了64例尸体肾移植。这64例移植中有48例经历了至少一次急性排斥反应。这些患者被平均分为两组,每组21名受者接受24例移植,一组仅接受化学免疫抑制治疗,另一组接受化学免疫抑制和放疗。仅接受化学免疫抑制治疗的对照组2年肾存活率为54.1%(13/24)。接受放疗和免疫抑制治疗的组,2年后肾存活率成功率为45.8%(11/24)。因此,在标准免疫抑制治疗基础上加用放疗,对急性排斥的肾移植似乎没有长期有益效果。鉴于放疗取得的结果令人失望,认为这种治疗方式应仅限于在特殊情况下作为全身免疫抑制有风险时的一种临时免疫抑制手段使用。